Is there a recommended Thymalin dose?

No. There is no validated modern human dose of Thymalin for any purpose. It is not an approved medicine in major Western jurisdictions, and it has never been through the dose-finding programme that would establish one. The figures that circulate online are extrapolations or echoes of older Russian research courses, presented as though they were established protocols — they are not. The published record describes what specific studies administered (repeated courses in an older observational cohort; defined concentrations in cell culture), which is a research reference, not a recommendation. Thymalin is supplied for research use only, not for human consumption, and this is not medical advice.

How should Thymalin be stored?

As a lyophilised powder, Thymalin is most stable at -20 degrees Celsius, protected from light. Once reconstituted with bacteriostatic water, the solution is generally kept refrigerated at 2-8 degrees Celsius and used within the window stated on the vendor’s documentation; the benzyl alcohol preservative in bacteriostatic water is what allows a reconstituted multi-use vial to remain usable across that window. Because Thymalin is a peptide preparation rather than a single defined molecule, documented batch consistency and a third-party certificate of analysis matter especially. These are storage notes for a research-grade material handled under research-use-only conditions, not for human consumption.

How many mg are in a Thymalin vial?

A common research vial is labelled Thymalin 10 mg, meaning 10 mg of total peptide mass per vial. Because Thymalin is a complex of short peptides rather than one molecule, the milligram figure refers to total peptide mass, not a defined molar quantity. Reconstituted with 2 mL of bacteriostatic water, a 10 mg vial yields 5 mg/mL total peptide; with 1 mL it yields 10 mg/mL. On a U-100 insulin syringe at 5 mg/mL, 10 units (0.1 mL) draws 0.5 mg of total peptide. These are laboratory-handling reference figures for a research-use-only material, not a dosing recommendation or medical advice.

Research · Thymalin cluster

Thymalin dosing research protocols — what the studies used, reconstitution, handling

Creator: Wellness Labs Editorial
Published: 2026-06-12
Keywords: Thymalin dosing, Thymalin dosing, Thymalin dose, how to reconstitute thymalin, thymalin reconstitution, thymalin protocol, thymalin 10mg, thymalin storage

Wellness Labs Editorial·12 June 2026·8 min read

Medically reviewed by

Wellness Labs Research Team · Research and Editorial

Last reviewed 1 June 2026

“What is the Thymalin dose?” is a question with no clean answer, and the honest version starts by saying so. There is no validated modern human dose of Thymalin for any purpose: it is not an approved medicine in major Western jurisdictions, and it has never been through the kind of dose-finding programme that would establish one. What exists instead is an older published research record — mostly from the St Petersburg gerontology school — describing the amounts and courses those studies administered. This spoke reports those figures descriptively, walks the reconstitution math, and is explicit throughout that this is a research reference, not a protocol to follow. It also flags a point that separates Thymalin from a tidy single peptide like Epitalon: Thymalin is a peptide complex, and that changes both the reconstitution arithmetic and the quality-control story.

TL;DR

There is no validated modern human dose of Thymalin — the figures that circulate are extrapolations and echoes of older Russian clinical courses, not established protocols. The published record describes Thymalin given in courses: a 266-patient observational study administered it as repeated courses over the first years of a multi-year follow-up [1], while mechanistic work used defined concentrations in culture [2]. Reconstitution is straightforward mechanically — bacteriostatic water down the vial wall, swirl, do not shake — but the key nuance is that Thymalin is a polypeptide complex, not a single defined peptide. A 10 mg vial in 2 mL gives 5 mg/mL of total peptide, so 10 units on a U-100 syringe (0.1 mL) draws 0.5 mg total — a mass, not a defined molar dose, because the complex has no single molecular weight. The multi-week “course” conventions are convention, not dose-response evidence. Research use only — not for human consumption. See the Thymalin parent synopsis.

Why there is no validated modern human dose

Before any number appears, it is worth being precise about what an “Thymalin dose” actually is. It is not a regulator-reviewed dosing instruction, because Thymalin is not an approved medicine in the major Western regulatory world — there is no marketed strength on a modern label, and no contemporary dose-ranging programme that ran to registration. The figures that circulate on forums and vendor pages are extrapolations: they reproduce amounts that appeared in older Russian research reports, or echo the “course” structure of that literature, and present those amounts as though they were established protocols. They are not.

That distinction is the entire point of this article, so it bears stating plainly: nothing below is a recommendation, and there is no validated modern human dose of Thymalin for any unapproved use. The contemporary mechanistic literature studies the preparation at the level of cell differentiation in culture [2]— it is not dose-finding work in people. Read every figure that follows as “what these studies administered”, never as “what to take”.

There is no validated modern human dose of Thymalin. The numbers that circulate are research-reference figures — what specific older studies administered — not a protocol for any person to follow.

What the published studies used

The Thymalin record is best read as a small set of research reports rather than a clinical guideline, and the figures everything online ultimately traces back to come from two very different kinds of work.

The older geroprotector observation. A 2003 report by Khavinson and Morozov described Thymalin, alongside the pineal peptide Epithalamin, administered as repeated courses — in that study Thymalin was given over roughly the first two to three years of a six-to-eight-year observational follow-up in an elderly cohort of around 266 people [1]. The relevant point here is the structure the study used: a course given periodically across the early part of a long observation, not a continuous daily regimen. The outcomes that paper reported are what that study reported — they are not a claim that Thymalin treats, prevents, or extends life, and they are not on offer here.
The mechanistic in-vitro work. Separately, modern laboratory work studies the preparation at defined concentrations in cell culture — for example, characterising how Thymalin influences the differentiation of human haematopoietic stem cells toward immune lineages [2]. These are culture concentrations chosen to probe a mechanism in a dish; they do not translate into a human dose, and the study does not present them as one.

The through-line is the same that runs through the whole Khavinson-family literature: the administration figures that exist were gathered to study the preparation — in an older observational cohort, or in a culture dish — rather than to establish a regimen for general use. They describe what those studies did. They do not describe a validated human dose, and presenting them as one would misrepresent what the papers say.

Reconstitution & the complex-not-single-peptide nuance

Mechanically, reconstituting Thymalin looks like reconstituting any lyophilised research peptide: introduce bacteriostatic water — sterile water with ~0.9% benzyl alcohol as a preservative — slowly down the inside wall of the vial rather than aiming the stream at the powder cake, then swirl gently to dissolve. Never shake; shaking shears and can damage peptide material. The general diluent and documentation framework lives in our how to reconstitute research peptides guide.

The substantive difference from a defined peptide is what the resulting concentration means. Epitalon is a single tetrapeptide with one sequence and one molecular weight, so a milligram figure maps cleanly onto a molar quantity. Thymalin is not a single molecule — it is a thymus-derived polypeptide preparation, a complex of short peptides. It therefore has no single molecular weight, and a milligram-per-millilitre figure describes the total peptide mass in solution, not a defined molarity. You can compute mass per draw precisely; you cannot compute a precise molar dose, because there is no single species to be molar in. The arithmetic below is laboratory handling math on total mass, not a use instruction.

Reconstitution math (research reference — total peptide mass)

A vial labelled Thymalin 10 mg reconstituted with 2 mL of bacteriostatic water yields 5 mg/mL of total peptide; with 1 mL it yields 10 mg/mL; with 5 mL it yields 2 mg/mL.
On a U-100 insulin syringe (100 units = 1 mL), 0.1 mL = 10 units. At 5 mg/mL (the 10 mg vial in 2 mL), 10 units = 0.1 mL = 0.5 mg total peptide; 4 units (0.04 mL) draws 0.2 mg; 20 units (0.2 mL) draws 1 mg.
These figures are total-peptide mass, not molar quantities. Because Thymalin is a complex with no single molecular weight, a precise molar dose cannot be calculated — only the total mass per draw.
Diluent: standard bacteriostatic water. Introduce it slowly down the vial wall, not onto the powder cake, then swirl — do not shake.
The free reconstitution calculator handles any vial-size / diluent-volume / draw-volume combination — remember its output is total mass for a preparation like this, not molarity.
These values are research-protocol reference figures for laboratory handling. They are not a human dosing recommendation — there is no validated modern human dose for any unapproved use, and Thymalin is not an approved medicine in major Western jurisdictions. For research use only — not for human consumption.

Storage & handling — and the QC nuance

Storage discipline is conventional: as a lyophilised powder Thymalin is most stable at -20°C, protected from light; once reconstituted, the solution is generally kept refrigerated at 2-8°Cand used within the window stated on the vendor’s documentation. Bacteriostatic water’s benzyl alcohol preservative is what allows a reconstituted multi-use vial to stay usable across that window rather than being a single-use preparation.

The quality-control nuance is where the complex really matters. For a defined peptide you verify identity against a single parent-ion mass — the molecule either shows up at its expected [M+H]⁺ or it does not. Thymalin offers no such single check, because there is no single molecule to mass. Instead, a research-grade Thymalin should be documented as an RP-HPLC profile — a characteristic chromatographic fingerprint — together with evidence of batch-to-batch consistency against that profile, rather than one parent-ion number. That makes the certificate of analysis more important for a preparation than for a defined peptide, not less: with no single mass to anchor to, consistency documentation is the main thing separating a credible research-grade supply from an unverified extract, and vendor-to-vendor variance is consequently wider.

Courses & “protocols” — convention vs evidence

The multi-week-course conventions that circulate — a run of consecutive days, a break, a repeat once or twice a year — are presented online as though they were established protocols. They are not derived from any modern controlled human dose-response work. They are convention: patterns that propagate through forums and vendor pages, often loosely echoing the “course” structure of the older geroprotector reports without any of the dose-finding rigour that would justify a specific schedule.

The honest distinction is between what the literature describes and what it validates. The published record describes Thymalin administered in courses in an older observational study [1] and studied at defined concentrations in culture [2]. Neither amounts to a modern controlled human trial that validates any particular course length, total mass, or frequency for general use. So a circulating “course” is a convention to recognise when reading the literature — not a dose-response-derived protocol, and not a recommendation made here.

A circulating “Thymalin course” is convention, not evidence. No modern controlled human trial has validated a particular total mass, frequency, or course length — the published courses describe an older observational study and culture work, not a protocol for people.

For what Thymalin is and where its research record stands, start with the Thymalin parent synopsis. For the molecular biology, see Thymalin mechanism research; for the immune and clinical literature, see Thymalin immune and clinical research. For general diluent and documentation handling, see how to reconstitute research peptides, and run any vial-size / diluent-volume / draw-volume combination through the free reconstitution calculator. Supply: Thymalin 10 mg research-consultation page.

Frequently asked questions

How do you reconstitute Thymalin?: Thymalin is supplied as a lyophilised powder and reconstituted with bacteriostatic water (sterile water with about 0.9% benzyl alcohol as preservative). The laboratory-handling method is to introduce the water slowly down the inside wall of the vial rather than aiming the stream at the powder cake, then swirl gently to dissolve — never shake, since shaking shears and can damage peptide material. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL of total peptide. This describes reconstitution mechanics for a research material only; Thymalin is for research use only, not for human consumption, and nothing here is a dosing instruction.
Is there a recommended Thymalin dose?: No. There is no validated modern human dose of Thymalin for any purpose. It is not an approved medicine in major Western jurisdictions, and it has never been through the dose-finding programme that would establish one. The figures that circulate online are extrapolations or echoes of older Russian research courses, presented as though they were established protocols — they are not. The published record describes what specific studies administered (repeated courses in an older observational cohort; defined concentrations in cell culture), which is a research reference, not a recommendation. Thymalin is supplied for research use only, not for human consumption, and this is not medical advice.
How should Thymalin be stored?: As a lyophilised powder, Thymalin is most stable at -20 degrees Celsius, protected from light. Once reconstituted with bacteriostatic water, the solution is generally kept refrigerated at 2-8 degrees Celsius and used within the window stated on the vendor’s documentation; the benzyl alcohol preservative in bacteriostatic water is what allows a reconstituted multi-use vial to remain usable across that window. Because Thymalin is a peptide preparation rather than a single defined molecule, documented batch consistency and a third-party certificate of analysis matter especially. These are storage notes for a research-grade material handled under research-use-only conditions, not for human consumption.
Why is Thymalin reconstitution different from a single peptide?: Because Thymalin is a polypeptide complex, not a single defined peptide. A defined peptide such as Epitalon has one sequence and one molecular weight, so a milligram figure maps cleanly onto a molar quantity. Thymalin has no single molecular weight, so a milligram-per-millilitre figure describes the total peptide mass in solution, not a defined molarity — you can compute mass per draw precisely, but you cannot compute a precise molar dose, because there is no single species to be molar in. This also changes quality control: identity is documented as an RP-HPLC profile plus batch-to-batch consistency, not a single parent-ion mass. Research use only.
How many mg are in a Thymalin vial?: A common research vial is labelled Thymalin 10 mg, meaning 10 mg of total peptide mass per vial. Because Thymalin is a complex of short peptides rather than one molecule, the milligram figure refers to total peptide mass, not a defined molar quantity. Reconstituted with 2 mL of bacteriostatic water, a 10 mg vial yields 5 mg/mL total peptide; with 1 mL it yields 10 mg/mL. On a U-100 insulin syringe at 5 mg/mL, 10 units (0.1 mL) draws 0.5 mg of total peptide. These are laboratory-handling reference figures for a research-use-only material, not a dosing recommendation or medical advice.